COMMUNIQUÉS West-GlobeNewswire

Biogen Announces Leadership Update
01/10/2019
Dr. Alfred Sandrock is named Executive Vice President, Research and Development and continues as Chief Medical Officer Dr. Alphonse Galdes appointed Executive Vice President, Pharmaceutical Operations and Technology Dr [...]
Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products
01/10/2019
MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary, RXMD Therapeutics Inc [...]
Editas Medicine to Participate in Upcoming Investor Conferences
01/10/2019
CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences [...]
Immunomedics to Present at the 2019 Cantor Global Healthcare Conference
01/10/2019
MORRIS PLAINS, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
GBT to Host Analyst & Investor Day on October 8 in New York
01/10/2019
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc., (GBT) (NASDAQ: GBT) today announced that it will host an Analyst & Investor Day to provide an update to the investment [...]
Alimera Sciences Announces Clinical Data Featuring the Benefits of ILUVIEN® to be Presented at the American Academy of Ophthalmology Annual Meeting
01/10/2019
Data highlight ILUVIEN’s advantages as the only therapy that consistently treats diabetic macular edema (DME) for up to 3 years ATLANTA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera [...]
iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest
01/10/2019
Company to exhibit ProFound AI for 2D and 3D Mammography in Europe NASHUA, N.H. and BUDAPEST, Hungary, Oct. 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]
Translate Bio Announces Upcoming MRT5005 Presentations at the 33rd Annual North American Cystic Fibrosis Conference
01/10/2019
LEXINGTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Helius Medical Technologies to Release Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019
01/10/2019
NEWTOWN, Pa., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that third [...]
Minerva Neurosciences Announces Update for Three Clinical Trials
01/10/2019
Company to host conference call at 8:30 a.m. today (dial-in information below) WALTHAM, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company [...]
AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss
01/10/2019
Initial focus on GJB2, the most common cause of genetic hearing loss in newborns GAINESVILLE, Fla. and CAMBRIDGE, Mass. and SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: [...]
Ocugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial Officer
01/10/2019
MALVERN, Pa., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Ocugen, Inc. , (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that [...]
Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress
01/10/2019
NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
01/10/2019
Data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow Could Lead to Improvement in the Clinical Management of Gynecological Cancers SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR [...]
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
01/10/2019
Biopharma star brings extensive translational research experience as company advances its clinical indications OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug [...]
PDMR Dealing/Issue of Equity
01/10/2019
Cambridge, UK and Indianapolis, US – 1 October 2019: Acacia Pharma Group plc (the "Company), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and [...]
CRISPR Therapeutics to Present at Upcoming Investor Conferences
01/10/2019
ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting
01/10/2019
Oral presentation to highlight Phase 1 data on safety, tolerability and target engagement of losmapimod in treatment of FSHD Company also announces updated preclinical data on FTX-6058 for potential treatment of sickle [...]
Microbix Presenting at StableView TECH19 Conference
01/10/2019
Meetings with Growth-Oriented Investors, October 3, 2019 MISSISSAUGA, Ontario, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix ® ), an innovator of clinical diagnostic materials and [...]

Pages